Tyra Biosciences, Inc. · NASDAQ:TYRA
Paradigm Biocapital Advisors LP reported a 5.80% stake in Tyra Biosciences, Inc. (Schedule 13G)
Event Sep 10, 2026 · Filed Sep 17, 2026
Paradigm Biocapital Advisors LP reported a 5.80% stake in Tyra Biosciences, Inc., 3,473,453 shares, as a passive investor on Sep 10, 2026. Filed Sep 17, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 3,473,453
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 5.80% | 3,473,453 |
| Paradigm BioCapital Advisors GP LLC | 5.80% | 3,473,453 |
| Senai Asefaw, M.D. | 5.80% | 3,473,453 |
| Paradigm BioCapital International Fund Ltd. | 5.10% | 3,060,595 |